Second Sight Medical Products Inc.'s Orion Cortical Visual Prosthesis system could reach a much larger patient population suffering from severe to profound retinitis pigmentosa once the implant clears regulatory hurdles. The Sylmar, Calif.-based firm has received full approval from the FDA to begin a five-patient feasibility clinical study for the device, which could restore sight to blind patients. Read More
